Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - EYEGATE PHARMACEUTICALS INC | v468727_ex5-1.htm |
| S-1MEF - S-1MEF - EYEGATE PHARMACEUTICALS INC | v468727_s1mef.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement of EyeGate Pharmaceuticals, Inc. on Form S-1 to be filed pursuant to Rule 462(b) of the Securities Act of 1933 on or about June 8, 2017 of our report dated February 23, 2017, on our audits of the consolidated financial statements as of December 31, 2016 and 2015 and for each of the years then ended, which report was included in the Annual Report on Form 10-K filed on February 23, 2017. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern.
/s/ EISNERAMPER LLP
New York, New York
June 8, 2017